Exor (EXO) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
24 Jun, 2026Executive summary
NAV per share grew 9% in 2024, reaching €178.78, driven by Ferrari's strong performance and disciplined capital allocation, with total NAV at €38.2 billion at year-end.
Major portfolio rotation over the past five years, with €19 billion in divestments and reinvestments, including a €3 billion Ferrari share sale and increased stakes in Philips and Institut Mérieux.
Concentration in four main holdings—Ferrari, Stellantis, CNH, and Philips—comprising over 70% of GAV, with Ferrari alone representing 43.2%.
Strong cash flow generation, with €1.5 billion from dividends and asset disposals.
Strategic shift to focus new investments through Lingotto, winding down EXOR Ventures, and maintaining long-term, active ownership.
Financial highlights
NAV per share rose from €164.0 to €178.8 in 2024, with Ferrari contributing +36% TSR, while Stellantis saw -36% TSR.
Total shareholder return for 2024 was 8%, with free cash flow 9.1 times the dividend paid and management costs at 6.6–11 bps of GAV.
LTV ratio improved to 9.6%, below the revised 15% target.
Profit for the period was €14.7 billion, including a one-off gain of €12.2 billion from adopting investment entity status under IFRS 10.
Dividend income totaled €1.1 billion, with major contributions from Stellantis, CNH, Philips, and Ferrari.
Outlook and guidance
Focus on improving company performance and disciplined capital allocation, with new investments targeted at 5% of GAV.
Ordinary dividend of €0.49 per share (~€100 million total) proposed for 2024, payable in May 2025.
Proceeds from Ferrari share sale to support new acquisitions and share buybacks.
Ongoing buyback program, with a new €1 billion tender offer announced at up to 10% premium.
Latest events from Exor
- NAV up 8.8–9% per share in H1 2024, with €11.8–€12.15B one-off gain from IFRS 10.EXO
H1 202424 Jun 2026 - NAV per share outperformed the MSCI World Index by 5 points, with €4.1B inflows and a €624M loss.EXO
H1 202528 May 2026 - NAV per share declined 8% in 2025, but liquidity and balance sheet strength improved.EXO
H2 202524 Mar 2026